UK Law Update
WORLD PRACTICE
Asia  Europe  USA  UK  Middle East  Africa

Low Pay Commission Holding Drop-In Session in Barnstaple on Minimum Wage

The Low Pay Commission has visited Barnstaple on 22nd May 2018 and will be visiting North Devon on 23 and 24 May 2018 as part of its annual consultation, including a drop-in session on Wednesday.

The visit to Barnstaple is part of a programme of visits the Low Pay Commission (LPC) is making around the UK during 2018 to gather information on how the National Living Wage is operating (see below for full list of visits). The LPC is also gathering evidence on the idea for a higher minimum wage for non-guaranteed hours, and its upcoming review of the minimum wage rates for young workers.

Professor Richard Dickens and Professor Sarah Brown will meet a number of representatives in North Devon to hear first hand what impact the National Living Wage is having on businesses and workers.

On Wednesday 23 May there will be a drop-in session for anyone who wants to share their experiences of the minimum wage. The session will be from 16:30-17:30 at the Imperial Hotel in Barnstaple. The LPC welcomes anyone to share their experience of the minimum wage, whether as a worker or employer. Commissioners will also be able to explain how the LPC works and how we make recommendations to the Government.

For more information on the above please click here.

Australian Life Sciences Company Medical Ethics Announce a £3 Million Investment in Wales

On 22nd May 2018 Welsh Secretary has announced a £3 Million Investment in Wales and also states that: “Investment is a real vote of confidence in Wales’ growing stature as a hotbed of life sciences expertise".

Dr Meredith Sheil, Technical Director & Co-Founder of Medical Ethics, has developed a world leading pain mitigation and wound healing technology for humans and animals.

Melbourne-based life science research and development company Medical Ethics has announced a direct investment of over £3 million in Wales over the next 3 years, making Cardiff its new base in the northern hemisphere.

Medical Ethics develop products that alleviate pain and minimise suffering associated with wounds and surgical procedures in animals. As a UK hub for life sciences expertise, Wales will provide the company with the ideal base to progress the development of its technology for humans.

Medical Ethics chose to invest in the UK for its expertise in a number of fields required for the commercialisation of the company’s technology. This includes regulatory affairs, manufacturing and clinical studies, tax subsidies and patent box incentives.

Currently Medical Ethics engages 18 independent service providers and consultants across the UK and has plans to expand its headcount. The company will also look to use other UK consultants and service providers as it addresses future regulatory and commercialisation requirements.

Medical Ethics has worked with the Department for International Trade (DIT) for 2 years, receiving advice, grant application assistance and introductions to key UK stakeholders including the Wales Wound Institute in Cardiff and Cardiff University, both of which the company now collaborates with. Without DIT’s support, the company would not have been able to identify these connections and would not have chosen the UK as a location for investment.

For more information on the above please click here.

Statement on the Proposed Merger Between Comcast Corporation and Sky Plc

As per the Written Ministerial Statement on 21st May 2018 by the Secretary of State for Digital, Culture, Media and Sport on the proposed merger between Comcast Corporation and Sky plc

On 7 May 2018, Comcast Corporation formally notified the European Commission of its intention to acquire the entire issued share capital of Sky plc.

Under section 58 of the Enterprise Act 2002 (“the Act”), the Secretary of State has the powers to intervene in certain media mergers on public interest grounds.

Having reviewed the relevant evidence available, I can confirm that I have today written to the parties to inform them that I am minded not to issue an EIN on the basis that the proposed merger does not raise concerns in relation to public interest considerations which would meet the threshold for intervention.

This is a quasi-judicial decision and I am required to make my decision independently, following a process that is scrupulously fair and impartial, and as promptly as quickly as possible.

I will now allow until 5pm on Thursday 24 May for interested parties to submit written representations, and I aim to come to a final decision on whether to intervene in the merger shortly.

For more information on the above please click here.

24 May 2018
In this issue:
 
F-116
Lajpat Nagar-1
New Delhi - 110 024, India
Ph: +91-11-29814816 / 29814817
Fax: +91-11-29815116
E: newdelhi@indiajuris.com
www.indiajuris.com
 
 
 
International Desks
 
Asia & Australia
M.P.Mehani
asia@indiajuris.com
 
Americas
Shivkumar Idnani
americas@indiajuris.com
 
UK & Europe
Sameer Rastogi
europe@indiajuris.com
 
Africa
Rahul Gupta
africa@indiajuris.com
 
Middle East
Dinesh Sabharwal
middleast@indiajuris.com
 
 
 
 
 
 
 
INDIA JURIS I www.indiajuris.com I Presentation, Awards & Rankings I Publications I Disclaimer